Christopher King in Proceedings of International Conference on Plasmodium vivax

Papers 3

Identification and immunological characterization of the ligand domain of Plasmodium vivax reticulocyte binding protein 1
Immunity, pathogenesis and vaccine discovery and development

Francis B Ntunmgia ; Richard Thomson Luque ¹ ; Sandra Galusic ¹ ; Letícia de Menezes Torres ² ; Sarah Frischmann ³ ; Gabriel Frato ³ ; Christopher King ³ ; John Adams ¹

¹ Center for Global Health & Infectious Diseases Research, College of Public Health, University of South Florida, Tampa, USA ;

² Center for Global Health & Infectious Diseases Research, College of Public Health, University of South Florida, Tampa, USA and Centro de Pesquisas René Rachou/FIOCRUZ, Belo Horizonte, Minas Gerais, Brazil ;

³ Center for Global Health and Diseases, Case Western Reserve University, Cleveland, USA

Vol.1, 2017 -
63207
Characterization of Functional Human Monoclonal Antibody to Plasmodium vivax Duffy Binding Protein from Malaria Exposed Individuals from Brazilian Amazon
Immunity, pathogenesis and vaccine discovery and development

Vanessa Cristina Nicolete ¹ ; Lenore Carias ² ; Sebastien Dechavanne ² ; Marcelo Urbano Ferreira ¹ ; Christopher King ³

¹ Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil ;

² Center for Global Health & Diseases, Case Western Reserve University, Cleveland, Ohio, USA ;

³ Center for Global Health & Diseases, Case Western Reserve University, Cleveland, Ohio, USA and United States Veterans Affairs Research Service

Vol.1, 2017 -
63212
Naturally-acquired antibodies to recombinant P. vivax antigens: identification of potential novel vaccine candidates
Immunity, pathogenesis and vaccine discovery and development

Camila Tenorio Franca ¹ ; Michael White ² ; Wen-Qiang He ³ ; Jessica B. Hostetler ⁴ ; Gabriel Frato ⁵ ; Indu Malhotra ⁵ ; Jakub Gruszczyk ³ ; Christele Huon ⁶ ; Enmoore Lin ⁷ ; Chetan Chitnis ⁸ ; Alan F. Cowman ⁹ ; Eizo Takashima ¹⁰ ; Takafumi Tsuboi ¹¹ ; Wai-Hong Tham ⁹ ; Rick M. Fairhurst ¹² ; Julian C. Rayner ¹³ ; Christopher King ¹⁴ ; Ivo Mueller ¹⁵

¹ Division of Population Health and Immunity, Walter and Eliza Hall Institute, 1G Royal Parade, Parkville 3052, Victoria, Australia. Department of Medical Biology, University of Melbourne, Parkville 3010, Victoria, Australia ;

² MRC Centre for Outbreak Analysis & Modelling, Department of Infectious Disease Epidemiology, Imperial College London AND Divisio ;

³ Division of Infection and Immunity, Walter and Eliza Hall Institute, 1G Royal Parade, Parkville 3052, Victoria, Australia ;

⁴ Malaria Programme, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom. Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 12735 Twinbr ;

⁵ Center for Global Health & Diseases, Case Western Reserve University, 10900 Euclid Avenue LC: 4983, Cleveland, OH 44106, United States of America ;

⁶ Malaria Parasite Biology & Vaccines Unit, Institut Pasteur, 25-28 Rue du Docteur Roux, Paris 75015, France ;

⁷ Malaria Immuno-Epidemiology Unit, PNG Institute of Medical Research, Madang Province, Yagaum, Papua New Guinea ;

⁸ International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, Delhi 110067, India ;

⁹ Department of Medical Biology, University of Melbourne, Parkville 3010, Victoria, Australia. Division of Infection and Immunity, Walter and Eliza Hall Institute, 1G Royal Parade, Parkville 3052, Victoria, Australia ;

¹⁰ Division of Malaria Research, Proteo-Science Center, Ehime University, 3 Bunkyo-cho, Matsuyama, Ehime 790-8577, Japan ;

¹¹ Division of Malaria Research, Proteo-Science Center, Ehime University, 3 Bunkyo-cho, Matsuyama, Ehime 790-8577, Japan ;

¹² Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 12735 Twinbrook Parkway, Rockville, Maryland 20852, United States of America ;

¹³ Malaria Programme, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom ;

¹⁴ Center for Global Health & Diseases, Case Western Reserve University, 10900 Euclid Avenue LC: 4983, Cleveland, OH 44106, United ;

¹⁵ Division of Population Health & Immunity, Walter and Eliza Hall Institute, Melbourne and Department of Parasites & Insect Vector

Vol.1, 2017 -
63838

Proceedings of International Conference on Plasmodium vivax

Christopher King

Identification and immunological characterization of the ligand domain of Plasmodium vivax reticulocyte binding protein 1

Characterization of Functional Human Monoclonal Antibody to Plasmodium vivax Duffy Binding Protein from Malaria Exposed Individuals from Brazilian Amazon

Naturally-acquired antibodies to recombinant P. vivax antigens: identification of potential novel vaccine candidates

Co-authors (27)

Ivo Mueller

Francis B Ntunmgia

Richard Thomson Luque

John Adams

Marcelo Urbano Ferreira

Letícia de Menezes Torres

Michael White

Gabriel Frato

Lenore Carias

Sebastien Dechavanne

Jessica B. Hostetler

Jakub Gruszczyk

Eizo Takashima

Takafumi Tsuboi

Wai-Hong Tham

Sandra Galusic

Sarah Frischmann

Vanessa Cristina Nicolete

Camila Tenorio Franca

Wen-Qiang He

Indu Malhotra

Christele Huon

Enmoore Lin

Chetan Chitnis

Alan F. Cowman

Rick M. Fairhurst

Julian C. Rayner